Belize vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Belize
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Belize rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Belize
- Kazakhstan
How they compare
Belize currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2009 it was Kazakhstan ahead.
Belize ranks 1st and Kazakhstan ranks 1st of 180 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 47.0% | 47.0% | Kazakhstan |
| 2010s | 35.6% | 92.9% | 57.3% | Kazakhstan |
| 2020s | 91.6% | 100.0% | 8.4% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Belize or Kazakhstan?
- Belize, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Belize and Kazakhstan?
- 0.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Kazakhstan?
- 14 years are reported by both, from 2009 to 2024.
- How do Belize and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Belize ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.